CDLX Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -9.11%, SMA50 -17.73%, SMA200 -42.17%). The stock’s 14-day RSI is 40.81 (neutral), while the ATR of 0.11 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -74.8% below its high and over 14.25% above its low. Average 10-day trading volume of 596.88 thousand shares is below the 3-month average of 795.72 thousand, indicating normal recent market interest.

Cardlytics, Inc. generated EPS of -$2.10 over the past year. Five-year average earnings growth is -40.23%. The latest quarter delivered EPS of -$1.36. The next quarter is forecast at -$0.21. Next year's EPS is expected at -$32.54. Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 0 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $3.00 to $2.00. The high target offers 237.08% upside. The low target suggests 124.72% downside. The mean target is $2.67. This offers 200.0% upside. Cardlytics, Inc. earnings surprise history is a mixed track record. The quarter that ended November 05, 2025, missed forecasts by 805.7%. The prior quarter beat by -18.75%. Over the last six quarters, Apple has recorded several small beats. These include -58.68% in August 07, 2024.

Cardlytics, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $11.42. This means the shares are trading below this model’s fair value.

Cardlytics, Inc. has 53.24 million shares outstanding. The public float is 46.54 million shares, elevated short interest at 16.63% of float. This equals 7.60 million shares. The short ratio is 5.43 days. Institutional investors hold 47.18% of the float. Insiders own 2.95%. SOSIN CLIFFORD holds 5.20 million shares, Gupta Amit has 659.64 thousand shares and Temsamani Karim Saad has 385.53 thousand shares. Over the past six months, insider transactions show net selling. They sold 140.26 thousand shares across 8 transactions.

Cardlytics, Inc. (NASDAQ:CDLX) closed at $0.89 USD, losing -$0.05 (-4.83%) from the previous close of $0.93. The stock is currently mid-range between its 52-week high and low $0.80 and $3.58. With a market capitalization of about $47.91 million, Cardlytics, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.03). Key stats such as the average daily volume over the past year has been around 819.87 thousand shares, volume is running light vs its 52-week average. Headquartered in Atlanta, GA, Cardlytics, Inc. operates in the Communication Services sector and the Advertising Agencies industry. Led by CEO Amit Gupta, the company employs approximately 440 people and listed since February 09, 2018. Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom.

Cardlytics, Inc. trades at a P/E ratio of -0.42, slightly below the S&P 500 average, with a price-to-sales ratio of 0.19 and a price-to-book ratio of -9.95 indicating negative book value, which may reflect financial stress. The P/FCF stands at -4.91, also below market averages.

Cardlytics, Inc. (NASDAQ:CDLX) shares are flat 0.0% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Cardlytics, Inc. trading at a premium to the broader market with a P/E of -0.42. Analyst sentiment is cautious, with the majority of ratings in In-Line territory and a mean price target of $32.99, suggesting 3622.22% upside. Our AI forecast model points to short-term weakness (-10.87% over two weeks), a medium-term fall (-79.69% over three months), and a longer-term gain (0.42% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Cardlytics, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.87%, with price expected at $0.79 by March 04, 2026, within a range of $0.66 to $0.91 3-Month Outlook: Projected fall of -79.69%, reaching $0.18 by May 19, 2026, with a range of $0.05 to $0.32. 1-Year Outlook: Projected gain of 0.42%, with price at $0.89 by February 18, 2027, within a range of $0.00 to $0.00.